Intrinsic Value of S&P & Nasdaq Contact Us

NextCure, Inc. NXTC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
59/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+17.5%

Stock Statistics — NXTC

NextCure, Inc. (NXTC) has a market capitalization of $34.22M and trades at $12.77. The 52-week range is 2.688-15.74.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-19.65.

The stock has a beta of 1.58, operates in the Healthcare sector.

Trading Data
Current Price$12.77
52-Week Range2.688-15.74
Volume52.25K
Avg Volume (30D)38.05K
Market Cap$34.22M
Beta (1Y)1.58
Company
IPO Date2019-05-09
Employees43
CEOMichael S. Richman
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS65343E2072
CUSIP65343E207
Income (Latest Year)
Gross Profit$-2.19M
EBITDA$-55.43M
Operating Income$-57.62M
Net Income$-55.84M
EPS$-19.65
EPS Diluted$-19.65
Shares Outstanding$2.84M
Balance Sheet (Latest Year)
Total Assets$50.18M
Current Assets$43.75M
Cash & ST Investments$41.82M
Total Liabilities$15.24M
Total Debt$4.15M
Net Debt$-21.83M
Total Equity$34.94M
Debt / Equity0.12
Valuation Ratios
P/E Ratio-0.6
P/B Ratio0.98
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message